Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more
Features and insights
Inside the Biology of 116 Years of Life: What Multiomics Reveals About Extreme Longevity
At enlightenbio, we are deeply committed to studying longevity and health span, which aligns with our personal and professional interests in biological science. For more on this, please see a couple of earlier...read more
New Therapy Potential of Targeted Protein Degradation
New approaches in drug discovery currently focus on the concept of a „magic bullet“ molecule. One that precisely targets an intended pharmacological role without off-target actions or unwanted side-effects. Traditional...read more
BEVIMI Launches: A New Bid to Bring Pharma-Grade Rigor to Brain Health
This past week, BEVIMI was officially announced. This new company aims to bring pharmaceutical-style rigor to the consumer brain-health market. Headquartered in Greenwich, Connecticut and led by co-founders Paul...read more
Strong Grip, Strong Future: A Key Predictor of Healthy Aging
And why your handshake may reveal more about your health than your blood pressure Indicators of Long-Term Health and Longevity In this next longevity blog, I’m excited to delve into phenotypic biomarkers of healthy...read more
Why Most Startups Fail: The Brutal Truth and How to Beat the Odds
Launching a startup is exhilarating—a whirlwind of big ideas, bold moves, sleepless nights, and passionate pitches. But behind the scenes, the harsh reality remains: Most startups fail. Depending on which study you...read more
It’s Not the Quantity but the Quality of Data That Enables AI/ML-Based Bioprocess Applications
Over the past 30 years, product titers have increased by almost 20% year over year (Langer and Rader, 2015). Since the 1990s, this has translated into dramatic increases in production, from an average of <1g/L to...read more
Neither AI nor ChatGPT Will Save Your Drug Discovery Pipeline …
AI is having a tough time generalizing molecule structures when your data is more scarce than the complexity of your problem allows for “Boring is good” is the mantra of successful engineering. This is in contrast to...read more
Rewiring Precision Medicine: How AI Is Transforming Science and Business
Artificial intelligence is transforming every link in the precision medicine value chain. From drug discovery and manufacturing to supply chain optimization and laboratory operation, AI’s impact is both deep and...read more
A Bean a Day Keeps the Doctor and Climate Change Away
Bean Fixing the Planet: Sustainable Nitrogen for Better Planetary Health Nitrogen plays a vital role as a fundamental component in the creation of life’s essentials, such as nucleotides and proteins. The introduction of...read more
